{"name":"Lumara Health, Inc.","slug":"lumara-health-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"oncology","drugs":[{"name":"Estradiol transdermal one 90 μL spray","genericName":"Estradiol transdermal one 90 μL spray","slug":"estradiol-transdermal-one-90-l-spray","indication":"Vasomotor symptoms associated with menopause","status":"phase_3"},{"name":"Placebo transdermal two 90 μL sprays","genericName":"Placebo transdermal two 90 μL sprays","slug":"placebo-transdermal-two-90-l-sprays","indication":"Other","status":"phase_3"},{"name":"Danazol Once Weekly","genericName":"Danazol Once Weekly","slug":"danazol-once-weekly","indication":"Endometriosis","status":"phase_2"},{"name":"Estradiol transdermal three 90 μL sprays","genericName":"Estradiol transdermal three 90 μL sprays","slug":"estradiol-transdermal-three-90-l-sprays","indication":"Vasomotor symptoms (hot flashes, night sweats) associated with menopause","status":"phase_3"},{"name":"Placebo transdermal one 90 μL spray","genericName":"Placebo transdermal one 90 μL spray","slug":"placebo-transdermal-one-90-l-spray","indication":"Other","status":"phase_3"},{"name":"Placebo transdermal three 90 μL sprays","genericName":"Placebo transdermal three 90 μL sprays","slug":"placebo-transdermal-three-90-l-sprays","indication":"Control arm in phase 3 clinical trial (specific indication unknown)","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"clindamycin phosphate/butoconazole nitrate","genericName":"clindamycin phosphate/butoconazole nitrate","slug":"clindamycin-phosphate-butoconazole-nitrate","indication":"Vaginal candidiasis","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Danazol Twice Weekly","genericName":"Danazol Twice Weekly","slug":"danazol-twice-weekly","indication":"Hereditary angioedema (HAE)","status":"phase_2"}]}],"pipeline":[{"name":"Estradiol transdermal one 90 μL spray","genericName":"Estradiol transdermal one 90 μL spray","slug":"estradiol-transdermal-one-90-l-spray","phase":"phase_3","mechanism":"Estradiol transdermal spray delivers the hormone estradiol through the skin to replace or supplement endogenous estrogen levels.","indications":["Vasomotor symptoms associated with menopause","Moderate to severe menopausal hot flashes and night sweats"],"catalyst":""},{"name":"Placebo transdermal two 90 μL sprays","genericName":"Placebo transdermal two 90 μL sprays","slug":"placebo-transdermal-two-90-l-sprays","phase":"phase_3","mechanism":"This drug does not have a known mechanism of action.","indications":[],"catalyst":""},{"name":"clindamycin phosphate/butoconazole nitrate","genericName":"clindamycin phosphate/butoconazole nitrate","slug":"clindamycin-phosphate-butoconazole-nitrate","phase":"phase_3","mechanism":"Clindamycin phosphate/butoconazole nitrate is an antibiotic and antifungal combination that works by inhibiting bacterial cell wall synthesis and disrupting fungal cell membranes.","indications":["Vaginal candidiasis","Bacterial vaginosis"],"catalyst":""},{"name":"Danazol Once Weekly","genericName":"Danazol Once Weekly","slug":"danazol-once-weekly","phase":"phase_2","mechanism":"Androgen receptor antagonist","indications":["Endometriosis","Fibrocystic breast disease"],"catalyst":""},{"name":"Danazol Twice Weekly","genericName":"Danazol Twice Weekly","slug":"danazol-twice-weekly","phase":"phase_2","mechanism":"Danazol is a synthetic androgen that suppresses pituitary gonadotropins and has immunomodulatory effects, used to treat conditions involving abnormal bleeding or immune dysfunction.","indications":["Hereditary angioedema (HAE)","Endometriosis","Idiopathic thrombocytopenic purpura (ITP)"],"catalyst":""},{"name":"Estradiol transdermal three 90 μL sprays","genericName":"Estradiol transdermal three 90 μL sprays","slug":"estradiol-transdermal-three-90-l-sprays","phase":"phase_3","mechanism":"Estradiol binds to estrogen receptors (ERα and ERβ) throughout the body to restore circulating estrogen levels in postmenopausal women.","indications":["Vasomotor symptoms (hot flashes, night sweats) associated with menopause","Moderate to severe vulvovaginal atrophy associated with menopause"],"catalyst":""},{"name":"Placebo transdermal one 90 μL spray","genericName":"Placebo transdermal one 90 μL spray","slug":"placebo-transdermal-one-90-l-spray","phase":"phase_3","mechanism":"A placebo transdermal spray that delivers no active pharmaceutical ingredient, used as a control in clinical trials.","indications":[],"catalyst":""},{"name":"Placebo transdermal three 90 μL sprays","genericName":"Placebo transdermal three 90 μL sprays","slug":"placebo-transdermal-three-90-l-sprays","phase":"phase_3","mechanism":"This is a placebo formulation with no active pharmacological mechanism.","indications":["Control arm in phase 3 clinical trial (specific indication unknown)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9fenFYWGxqX0J1eWpGRDBlejlEdmxpWTZlVlhnVVRfdzRTWlhCeUwtdzhNUUFBdVhZVjdVOW9Ia3RYb3VVMVJLbW02VlRxd2VsLVB1R19WNnVYUkI5bkFOZzBucFN6emNhaFZz?oc=5","date":"2020-12-10","type":"pipeline","source":"BioSpace","summary":"BioSpace Movers & Shakers, Dec. 11 - BioSpace","headline":"BioSpace Movers & Shakers, Dec. 11","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE0tNmlsWXFJam5hZTcwYWZuU0FITkFlOURFUlVaUnRZOENBSDBOWWpmTEJyT1p6NzAtcDJsTlNud3JwNm83TG9PbUFnR0xFWHFtTEdYZlYwZ3hWWFJWMUJlODdoM205TTh4eWZOOU1PWTgtNTVoUWhWazNOTks?oc=5","date":"2019-06-03","type":"pipeline","source":"Contract Pharma","summary":"Avadel Pharma Appoints CEO - Contract Pharma","headline":"Avadel Pharma Appoints CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNRzlwNEw2bHd0aTQ1bU9jenNMOUdfZ29XZ084UVlDbjVMeFFyVzRsaTZaTmxZNnRZRUFSa1RpNkFTYXBBR0Y1M0twbjFRVzZKd2IzUGdNUVRxcXV5OFFyTHpqSHZzdVpTRzVrNzNsZF83dDN4RGRPZ0ViZi1Pb1FCSG9oZHRyakJhdFhrTzQzZHA1M2xUb2JoVHdtZlZxNG5vMjRZUklBazh1ejdaZFhHZUpfYm1GUQ?oc=5","date":"2018-08-15","type":"pipeline","source":"Fierce Pharma","summary":"Depomed joins ranks of scandal-plagued pharmas rehabbing their reputations with a name change - Fierce Pharma","headline":"Depomed joins ranks of scandal-plagued pharmas rehabbing their reputations with a name change","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNczU3Mmw3T1Q2T1paRGlHY1EzclJVa0lyblJuRlRvek5yd0F2RnFiaWp0YmlLWUNwZ0NrazMxWjJnNkpsLVJ5eFc0ZVNiNHRWYXRFTVIwalduTnFoei1CLWtORFc3N3g4WW1yT1lzRHdVTldvVHA1Tm92Q2dfdzFXVFk5NF9CMkYtOVdmSzV3OTNDSE5VTU9vNU9BYV9RLVJvYi1uUTdqRkMyMmZ6MDZTTkIyQTZQQWZCZmEzMVdQcnFFOERsTmNGUDN0UkRRbXNqQ2kwTEhGV0NLdldMR00wd09wS3ZmZHUzVTFyUjBkeEI0TW1CN2tkMkFXZmlWSDA?oc=5","date":"2014-09-29","type":"pipeline","source":"PR Newswire","summary":"Perrigo Enters New Therapeutic Category With The Acquisition Of Women's Health Product Portfolio From Lumara Health - PR Newswire","headline":"Perrigo Enters New Therapeutic Category With The Acquisition Of Women's Health Product Portfolio From Lumara Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPUTgwS2dMZ1lPa0NJWlozZXBwRWNvbS0zR242RXBBTEV5MFI2Q1JzTF9qSWpnU09TYmZnSk1OMzBnTll3ZFdLT19oQUwxbENqSEc5MWlMSmt6QllQUzBiN05tVmtwTzhHUFFBNVVvMng4ZFE3bVRyNVVEWnJQem16emY5LWM2ZE5vRnFvUHN6V2o0d1NUWGtTeUJmU3pyZw?oc=5","date":"2014-09-29","type":"deal","source":"thestreet.com","summary":"Amag, Perrigo Buy Lumara in Two-Step Deal Valued at $1.1B - thestreet.com","headline":"Amag, Perrigo Buy Lumara in Two-Step Deal Valued at $1.1B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQUVM1M3JHOXM0ckt3eVBwR3htXzBXQUhYSW1RRjlScUFSeGdDTzg5ei03RTl1amxIbjhmZG5rWmpGZE84VlIzcmJjYUdNcWVrS1ppV1k4MXJuWmdHSWNCVEw3QmdPSXkzckVDdUh6S0J4aUZkYzJENnlyTjhmY1BwYjJHdTh1N3g3TVNGWTJXVWg1UnZxVGZUYzFDdzd2c0M3djJyakxNek4?oc=5","date":"2014-09-29","type":"deal","source":"The Business Journals","summary":"Former KV Pharmaceutical to be acquired - The Business Journals","headline":"Former KV Pharmaceutical to be acquired","sentiment":"neutral"}],"patents":[],"drugCount":8,"phaseCounts":{"phase_3":6,"phase_2":2},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}